Sam Brusco, Associate Editor01.07.22
Wearable medical robotics firm Myomo released MyoPro 2+, an enhanced version of its MyoPro powered brace. Patients can expect to receive deliveries this month.
MyoPro 2+ is lighter in weight, easier to don, more comfortable, and has improved grasp functionality. There are also more powerful and simplified configuration options for clinicians and users, including customizable speed control to foster more natural arm movement.
“The user experience is at the core of all our innovations,” Shiven Ruparel, Myomo’s director of product management told the press. “With this enhancement, not only will our adult and adolescent patients engage with the MyoPro 2+ in ways that make it more functional for them, they will also see a dramatic improvement in the ability to tailor the device to their preferences, including two harness options and more than 30 color and pattern styles, enabled by the introduction of 3D printing of the orthotic components.”
The new technology will be fabricated in-house at the company’s Boston headquarters.
“Our goals for MyoPro 2+ were to improve the experience and functionality for our users while at the same time reducing costs and cycle times for Myomo,” Myomo CEO Paul R. Gudonis said. “Our field trials indicate we have accomplished both. Myomo is growing rapidly, and these enhancements are expected to further support our ability to scale up and offer increased upper limb functionality to more and more people.”
MyoPro 2+ is lighter in weight, easier to don, more comfortable, and has improved grasp functionality. There are also more powerful and simplified configuration options for clinicians and users, including customizable speed control to foster more natural arm movement.
“The user experience is at the core of all our innovations,” Shiven Ruparel, Myomo’s director of product management told the press. “With this enhancement, not only will our adult and adolescent patients engage with the MyoPro 2+ in ways that make it more functional for them, they will also see a dramatic improvement in the ability to tailor the device to their preferences, including two harness options and more than 30 color and pattern styles, enabled by the introduction of 3D printing of the orthotic components.”
The new technology will be fabricated in-house at the company’s Boston headquarters.
“Our goals for MyoPro 2+ were to improve the experience and functionality for our users while at the same time reducing costs and cycle times for Myomo,” Myomo CEO Paul R. Gudonis said. “Our field trials indicate we have accomplished both. Myomo is growing rapidly, and these enhancements are expected to further support our ability to scale up and offer increased upper limb functionality to more and more people.”